Dates: 26 March 2017
7-9, Chemin du Petit-Saconnex, 1211 Genève, Switzerland
In collaboration with the World Health Organization, the MPP held its third industry event to brief private sector partners on progress in medicine development and rollout on 27 March in Geneva. This year’s discussion, Forecasts vs. Reality: Are we on Course? focused on MPP-WHO developed joint forecasts for HIV medicines as well as hepatitis C treatment uptake. MPP’s Sandeep Juneja and Aastha Gupta and the WHO’s Daniel Low-Beer, Boniface Dongmo, Vincent Habiyambere and Marc Bulterys were among presenters. Shailesh Pednekar, Hetero; Helen McDowell, ViiV Healthcare; Prashant Sisodia, Mylan and Martin Auton from the Global Fund participated in the event as well.
Access the MPP-WHO forecast presentation: Forecasted demand for Current and New ARV medicines in low- and middle-income countries, 2016-2026
Access the agenda and presentations
Access more pictures
Press and Media
The Medicines Patent Pool (MPP) is a United Nations-backed public health organisation working to increase access to and facilitate the development of life-saving medicines for low- and middle-income countries. Through its innovative business model, MPP partners with civil society, governments, international organisations, industry, patient groups, and other stakeholders to prioritise and license needed medicines and pool intellectual property to encourage generic manufacture and the development of new formulations.
To date, MPP has signed agreements with 22 patent holders for 13 HIV antiretrovirals, one HIV technology platform, three hepatitis C direct-acting antivirals, a tuberculosis treatment, a cancer treatment, four long-acting technologies, a post-partum haemorrhage medicine, three oral antiviral treatments for COVID-19 and 16 COVID-19 technologies.
MPP was founded by Unitaid, which continues to be MPP’s main funder. MPP’s work on access to essential medicines is also funded by the Swiss Agency for Development and Cooperation (SDC), Government of Canada, the World Intellectual Property Organization (WIPO) and the Government of Flanders. MPP’s activities in COVID-19 are undertaken with the financial support of the Japanese Government, the French Ministry for Europe and Foreign Affairs, the German Agency for International Cooperation, and SDC.